WEDNESDAY, MARCH 14, 2012 |
|
3:00 – 7:00 PM |
Registration |
The George Washington University
Marvin Center, 3rd Floor, Cafritz Conference Center
800 21st Street, N.W
Between H and I Streets, N.W. |
7:30 PM |
Welcome |
Allan L. Goldstein and Enrico Garaci |
|
|
Co-Chairs of Symposium |
7:40 PM |
Keynote Speakers |
Luigina Romani (U. of Perugia, Perugia, Italy): Thymosin α1: environment-dependent mechanisms of a drug's pleiotropy
Deepak Srivastava (U. of California, San Francisco, CA): Thymosin β4 in cardiac regeneration |
8:30 PM |
Reception |
|
|
|
|
THURSDAY, MARCH 15, 2012
|
|
7:00 – 8:00 AM |
Registration and Breakfast |
|
8:00 – 10:00 AM |
Plenary Session I |
|
|
Thymosins: Chemistry, Genetics, Receptors, Signaling, and Multi-Functionality |
|
|
Co-Chairs: |
Bruce Zetter & Cynthia Tuthill |
| |
Speakers: |
John Edwards (University of Glasgow, Glasgow, Scotland, UK): Beta Thymosins: the family history |
|
|
Milica Radisic (U. of Toronto, Toronto, Canada): Controlled delivery of Thymosin β4 for
tissue engineering and cardiac regenerative medicine |
|
|
Francesca Fallarino (U. of Perugia, Perugia, Italy): The unexpected interface between Thymosin α1 toll-like receptors and IDO |
|
|
Gavino Faa (U. of Cagliari, Italy): Expression pattern of Tβ4 in the adult human liver |
|
|
Paola Sinibaldi/Francesca Pica (U. of Rome, Rome, Italy): Thymosin α1:
Transcription & Cancer |
|
|
Yeu Su (National Yang-Ming University, Taipei, Taiwan): Thymosin β4: from a
G-actin binding protein to a malignancy promoter for human colon cancer |
|
|
Hiroshi Ueda (Nagasaki University, Nagasaki, Japan): Prothymosin alpha: its mechanisms for non-vesucular release and receptor in central nervous system |
|
|
[Additional short talks selected from abstracts] |
10:00 AM |
Coffee Break – 30 minutes |
|
10:30 PM – 12:30 PM |
Plenary Session II |
|
|
Thymosins: Molecular Markers, Wound Healing, Fibrosis, Inflammation, and Hypoxia |
|
|
Co-Chairs: |
Ewald Hannappel & Paul Naylor |
|
Speakers: |
Gavino Faa (U. of Cagliari, Italy): Expression pattern of Tβ4 in the adult human liver |
|
|
Karina Reyes-Gordillo (The George Washington University School of Medicine, Washington, DC):
Thymosin β4 & liver fibrosis |
|
|
Oscar A. Carretero (Henry Ford Hospital, Detroit, MI): Effect of Ac-SDKP in
experimental autoimmune myocarditis and in hypertension |
| |
|
Enrico Conte (University of Catania, Catania, Italy): Thymosin β4 protects C57BL/6 mice from bleomycin-induced damage in the lung |
| |
|
Sprague W. Hazard (Penn State College of Medicine, Hershey, PA): The effects of Thymosin β4 on myofibroblasts, wound breaking strength and cytoskeletal organization |
|
|
Hee-Jae Cha (Kosin University, Busan, S. Korea): Thymosin β4 stabilizes hypoxia-inducible factor-1α by oxygen independent manner |
12:30 – 2:00 PM |
Lunch |
|
2:00 – 4:00 PM |
Plenary Session III |
|
|
Thymosin β4: Cardiovascular Protection, Neuroplasticity and Regeneration, and Stem
Cell Differentiation |
|
|
Co-Chairs: |
Deepak Srivastava & Paul Riley |
|
Speakers: |
Sudhiranjan Gupta (Texas A&M Health Science Center,
Temple, TX): Thymosin beta 4 and cardiac protection: implication of inflammation and fibrosis
|
|
|
Nicola Smart (University College London, London,
England): Thymosin β4 facilitates myocardial regeneration via activated epicardial progenitor cells |
|
|
Christian Kupatt (Ludwig-Maximilians-University of Munich, Munich, Germany):
Thymosin β4-induced biological bypasses: Mechanisms of arteriogenesis in ischemic muscle tissue |
|
|
Dan Morris (The Henry Ford Health System, Detroit, MI): Mechanisms of
Tβ4-mediated oligodendrogenesis after stroke |
| |
|
R. Hinkel (Klinikum der Universitat Munchen, Munchen, Germany): Thymosin β4: molecular mechanism in angio- /arteriogenesis |
|
|
Christoffer Stark (Turku University Central Hospital, Finland): Cardioprotective effects of Thymosin β4 after myocardial infarction |
4:00 – 5:30 PM |
Poster Presentations and Coffee |
|
7:00 – 9:30 PM |
Awards Banquet |
Italian Embassy
3000 Whitehaven Street, N.W.
Washington, DC |
|
2012 Abraham White Scientific, Humanitarian, and Public Service Awardees
|
To be announced |
|
|
To be announced |
|
|
|
FRIDAY, MARCH 16, 2012
|
|
7:00 – 8:00 AM |
Breakfast |
|
8:00 – 10:00 AM |
Plenary Session IV |
|
|
Thymosin α1: Immunomodulation, Immunopharmacology, Infectious Diseases, and Cancers |
|
|
Co-Chairs: |
Enrico Garaci & Roberto Camerini |
|
Speakers: |
Hemmo Drexhage (Erasmus Medical College, Rotterdam, The Netherlands): The gene
expression abnormalities of motility disturbed monocytes in recurrent and chronic purulent rhino-sinusitis. Correction by thymosins. |
|
|
Michele Maio (Centro di Riferimento Oncologico of Aviano, Italy):
Thymosin α1 in melanoma: from the clinical trial setting to the daily practice |
|
|
Annalucia Serafino (National Research Council of Italy, Rome, Italy): Thymoin α1 as
a stimulatory agent for the early macrophage-mediated immune defence against fungal pathogens |
|
|
Andrea Velardi (U. of Perugia, Perugia, Italy): Bone marrow transplanted patients
treated with Tα1 to prevent infections |
|
|
Roberto Camerini (Sigma-Tau, Rome, Italy): Thymosin α1 as adjuvant for H1N1 vaccination in end stage renal disease patients |
|
|
Cynthia Tuthill (SciClone Pharmaceuticals, San Francisco, CA): Thymosin α1 continues to show promise as an enhancer for vaccine response |
10:00 AM |
Coffee Break |
|
10:30 AM – 12:30 PM |
Plenary Session V |
|
|
Clinical and Preclinical Applications of Thymosin β4: Wound Healing, Eye Injuries,
Cardiovascular Diseases and Neurological Injuries |
|
|
Co-Chairs: |
David Crockford & Gabriel Stone |
|
Speakers: |
Mark Hardy (Columbia University College of Physicians and Surgeons and
NewYork-Presbyterian Hospital, New York City, NY): The role of Thymosin β4 in healing of acute and chronic wounds |
|
|
Gabe Sosne (Wayne State University School of Medicine, Kresge Eye Institute, Detroit, MI)Thymosin beta 4: A potential novel dry eye therapy |
|
|
Xe Xiong/Michael Chopp (The Henry Ford Health System, Detroit, MI): Post-traumatic treatment with Thymosin β4 improves functional recovery after traumatic brain injury in rats: neuroprotective and neurorestorative effects |
12:30 – 2:00 PM |
Lunch |
|
2:00 – 3:30 PM |
Plenary Session VI |
|
| |
Late Breaking Paper Session |
|
| |
Co-Chairs: |
Hynda Kleinman & Allan Goldstein |
|
Speakers: |
Domenico Schillaci (Università degli Studi di Palermo, Palermo, Italy): Fragments of beta-thymosin from the sea-urchin Paracentrotus lividus as novel antimicrobial peptides against Staphylococcal biofilms
Czeslaw S. Cierniewski (Medical University of Lodz, Lodz, Poland): Thymosin β4 promotes migration of endothelial cells without the intracellular Ca2+ elevation
Javier Paino (BioCell Peru Stem Cell Research Institute, Lima, Peru): Stem cells use biologically active peptides in tissue repair. New technique in the re-epithelialization of burn injuries with cultured umbilical cord cells. Experimental treatment in Rex rabbits
Christine App (University of Erlangen-Nuremberg, Erlangen, Germany): Thymosin β4 can be labeled with N-(4-Azido-2-nitrophenyl)-putrescine (ANP), a heterobifunctional photo-cross-linking reagent
Jana Knop (Friedrich-Alexander-University, Erlangen, Germany): Molecular investigations on Thymosin β4-antibodies |
3:30 PM |
Adjournment |
|
|
|
|